Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

1.24
Delayed Data
As of Feb 24
 +0.02 / +1.64%
Today’s Change
0.83
Today|||52-Week Range
5.75
-40.95%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.22
Today’s open1.20
Day’s range1.18 - 1.24
Volume286,458
Average volume (3 months)634,773
Market cap$34.2M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+30.34%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.03+2.46%
RTTRRitter Pharmaceutica...-0.06-2.03%
OHRPOHR Pharmaceutical I...+0.01+0.83%
DFFNDiffusion Pharmaceut...-0.45-11.63%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs